169 related articles for article (PubMed ID: 30053873)
1. HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells.
Zhang Y; Xu Z; Ding J; Tan C; Hu W; Li Y; Huang W; Xu Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):174. PubMed ID: 30053873
[TBL] [Abstract][Full Text] [Related]
2. RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells.
Wei X; Xu Y; Xu FF; Chaiswing L; Schnell D; Noel T; Wang C; Chen J; St Clair DK; St Clair WH
Cancer Res; 2017 Mar; 77(6):1345-1356. PubMed ID: 28108513
[TBL] [Abstract][Full Text] [Related]
3. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.
Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH
Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728
[TBL] [Abstract][Full Text] [Related]
4. The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer.
Chaiswing L; Xu F; Zhao Y; Thorson J; Wang C; He D; Lu J; Ellingson SR; Zhong W; Meyer K; Luo W; St Clair W; Clair DS
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742868
[TBL] [Abstract][Full Text] [Related]
5. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells.
Xu Y; Fang F; St Clair DK; Josson S; Sompol P; Spasojevic I; St Clair WH
Mol Cancer Ther; 2007 Jul; 6(7):2048-56. PubMed ID: 17604335
[TBL] [Abstract][Full Text] [Related]
6. Blockage of RelB expression by gene silencing enhances the radiosensitivity of androgen‑independent prostate cancer cells.
Zhu HC; Qiu T; Dan C; Liu XH; Hu CH
Mol Med Rep; 2015 Feb; 11(2):1167-73. PubMed ID: 25370388
[TBL] [Abstract][Full Text] [Related]
7. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells.
Josson S; Xu Y; Fang F; Dhar SK; St Clair DK; St Clair WH
Oncogene; 2006 Mar; 25(10):1554-9. PubMed ID: 16261162
[TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between PSA and IL-8 in prostate cancer: an insight into a NF-κB-mediated mechanism.
Xu Y; Fang F; St Clair DK; St Clair WH
PLoS One; 2012; 7(3):e32905. PubMed ID: 22403723
[TBL] [Abstract][Full Text] [Related]
9. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells.
Holley AK; Xu Y; St Clair DK; St Clair WH
Ann N Y Acad Sci; 2010 Jul; 1201():129-36. PubMed ID: 20649549
[TBL] [Abstract][Full Text] [Related]
10. SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation.
Xu Y; Fang F; St Clair DK; Sompol P; Josson S; St Clair WH
Mol Cancer Ther; 2008 Aug; 7(8):2367-76. PubMed ID: 18723484
[TBL] [Abstract][Full Text] [Related]
11. [RNA interference of RelB enhances the radiosensitivity of prostate cancer cell line RM-1 in mice].
Zhu B; Yang LY; Zhao XK; Jiang HY; Zhu L
Zhonghua Nan Ke Xue; 2012 Jul; 18(7):595-9. PubMed ID: 22994043
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation.
Mineva ND; Wang X; Yang S; Ying H; Xiao ZX; Holick MF; Sonenshein GE
J Cell Physiol; 2009 Sep; 220(3):593-9. PubMed ID: 19373868
[TBL] [Abstract][Full Text] [Related]
13. HMGN5 knockdown sensitizes prostate cancer cells to ionizing radiation.
Su B; Shi B; Tang Y; Guo Z; Yu X; He X; Li X; Gao X; Zhou L
Prostate; 2015 Jan; 75(1):33-44. PubMed ID: 25307178
[TBL] [Abstract][Full Text] [Related]
14. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
15. A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells.
Sun Y; St Clair DK; Xu Y; Crooks PA; St Clair WH
Cancer Res; 2010 Apr; 70(7):2880-90. PubMed ID: 20233868
[TBL] [Abstract][Full Text] [Related]
16. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.
Sun Y; St Clair DK; Fang F; Warren GW; Rangnekar VM; Crooks PA; St Clair WH
Mol Cancer Ther; 2007 Sep; 6(9):2477-86. PubMed ID: 17876045
[TBL] [Abstract][Full Text] [Related]
17. Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate Cancer.
Conti S; Vexler A; Hagoel L; Kalich-Philosoph L; Corn BW; Honig N; Shtraus N; Meir Y; Ron I; Eliaz I; Lev-Ari S
Integr Cancer Ther; 2018 Dec; 17(4):1225-1234. PubMed ID: 30043669
[TBL] [Abstract][Full Text] [Related]
18. KEAP1 is a redox sensitive target that arbitrates the opposing radiosensitive effects of parthenolide in normal and cancer cells.
Xu Y; Fang F; Miriyala S; Crooks PA; Oberley TD; Chaiswing L; Noel T; Holley AK; Zhao Y; Kiningham KK; Clair DK; Clair WH
Cancer Res; 2013 Jul; 73(14):4406-17. PubMed ID: 23674500
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer.
Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP
Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324
[TBL] [Abstract][Full Text] [Related]
20. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
